January 2022

NEUROSCIENCES

ALS THERAPY SHOULD TARGET BRAIN, NOT JUST SPINE

The brain is indeed a target for treating ALS (amyotrophic lateral sclerosis), Northwestern Medicine scientists have discovered. This flips a long-standing belief that the disease starts in the spinal motor neurons and any therapy would need to target the spine as the key focus.
 
A new Northwestern Medicine study published in Nature Gene Therapy shows the degeneration of brain motor neurons is not merely a byproduct of the spinal motor neuron degeneration, as had been previously thought.
 
Lead study author P. Hande Ozdinler, PhD, associate professor of Neurology at Northwestern Medicine, explains the findings in a recent Better Edge podcast.

Listen to the podcast >

Read the article in the Northwestern University Feinberg School of Medicine News Center . 
Hande Ozdinler, PhD, is an associate professor of Neurology in the Division of Neuromuscular Disease at Northwestern Medicine.

Refer a Patient

Northwestern Medicine welcomes the opportunity to collaborate with you on the care of your patients. 

You May Also Like